Partnership
1 min read
Accenture has strategically invested in RyghtAI via Accenture Ventures, aiming to revolutionize clin...
The AMW Read
This updates the player map for Vertical AI in Healthcare/Bio with a strategic investment by Accenture into RyghtAI's agentic clinical research platform.
NoveltySignificance
Healthcare & Bio · Player Map
Accenture has strategically invested in RyghtAI via Accenture Ventures, aiming to revolutionize clinical research within the life sciences industry. This collaboration utilizes RyghtAI's agentic AI platform to expedite crucial stages of drug development: trial feasibility, site selection, and patient recruitment. This investment underscores Accenture's broader commitment, part of its $3 billion AI initiative over three years, to enhance AI capabilities and drive client innovation.
#AI #LifeSciences #Accenture #RyghtAI #ClinicalResearch #Innovation